Paresis - 64 Studies Found
| Active, not recruiting |
: A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis : Idiopathic Gastroparesis : 2012-06-18 : Drug: Olanzapine Subjects will initially start on olanzapine 2.5 mg per mouth daily. Subjects will retur |
| Terminated |
: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis : Gastroparesis : 2011-03-24 :
|
| Recruiting |
: Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis : Gastroparesis : 2014-06-06 |
| Terminated |
: Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 : Diabetic Gastroparesis : 2012-08-10 :
|
| Completed |
: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis : Tropical Spastic Paraparesis : 2002-05-01 |
| Completed |
: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV-I-Associated Myelopathy : 2011-04-25 : Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
| Completed |
: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV I Associated Myelopathy : 2008-10-15 : Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
| Recruiting |
: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis : HTLV-1 : 2006-07-12 : Drug: Hu MiK-Beta-1 |
| Terminated |
: Safety and Efficiency Study of Valproic Acid In HAM/TSP : HTLV-I-Associated Myelopathy : 2007-08-20 : Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
| Recruiting |
: Evaluation of Patients With HAM/TSP :
: 1999-11-03 |